PriceTargets.com logo

Laboratory Co. of America - LH Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $270.62
  • Forecasted Upside: 8.29%
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 11 Buy Ratings
  • 1 Strong Buy Ratings
$249.91 As of 05/13/2025 12:13 PM ET
▼ -1.03 (-0.41%)

This chart shows the closing price for LH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
MarAprMay$250.89Closing price on 05/12/25:
Get New Laboratory Co. of America Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LH

Analyst Price Target is $270.62
▲ +8.29% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Laboratory Co. of America in the last 3 months. The average price target is $270.62, with a high forecast of $300.00 and a low forecast of $230.00. The average price target represents a 8.29% upside from the last price of $249.91.

This chart shows the closing price for LH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
5/248/2411/242/255/255/26$135$176$217$259$300Closing price on 05/12/25: $250.89High$300.00Average$270.62Low$230.00




Current Consensus is Moderate Buy

The current consensus among 15 contributing investment analysts is to moderate buy stock in Laboratory Co. of America. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
2/18/2024
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
5/18/2024
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
8/16/2024
  • 1 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
11/14/2024
  • 1 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
2/12/2025
  • 1 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
4/13/2025
  • 1 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
5/13/2025

Latest Recommendations

  • 1 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/12/2025Truist FinancialBoost TargetBuy ➝ Buy$274.00 ➝ $290.00
5/6/2025Piper SandlerReiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.00
4/30/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$240.00 ➝ $250.00
4/30/2025Robert W. BairdBoost TargetOutperform ➝ Outperform$253.00 ➝ $267.00
4/11/2025Truist FinancialLower TargetBuy ➝ Buy$285.00 ➝ $274.00
4/10/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$260.00 ➝ $240.00
4/2/2025Redburn AtlanticInitiated CoverageBuy$276.00
3/4/2025CitigroupUpgradeNeutral ➝ Buy$250.00 ➝ $300.00
2/10/2025Piper SandlerBoost TargetNeutral ➝ Neutral$240.00 ➝ $260.00
2/7/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$271.00 ➝ $260.00
2/6/2025Jefferies Financial GroupBoost TargetBuy ➝ Buy$275.00 ➝ $290.00
2/3/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$249.00 ➝ $271.00
1/28/2025UBS GroupLower TargetBuy ➝ Buy$293.00 ➝ $286.00
1/7/2025Evercore ISIUpgradeIn-Line ➝ Outperform$260.00 ➝ $265.00
12/17/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$260.00 ➝ $270.00
12/13/2024Bank of AmericaBoost TargetBuy ➝ Buy$262.00 ➝ $271.00
12/10/2024Jefferies Financial GroupReiterated RatingBuy$265.00 ➝ $275.00
10/30/2024Hsbc Global ResUpgradeHold ➝ Strong-Buy
10/30/2024HSBCUpgradeHold ➝ Buy
10/28/2024Piper SandlerBoost TargetNeutral ➝ Neutral$235.00 ➝ $240.00
10/25/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$234.00 ➝ $249.00
10/25/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$282.00 ➝ $289.00
10/16/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$249.00 ➝ $234.00
10/1/2024Piper SandlerInitiated CoverageNeutral$235.00
9/24/2024Evercore ISILower TargetIn-Line ➝ In-Line$250.00 ➝ $240.00
9/23/2024Jefferies Financial GroupBoost TargetBuy ➝ Buy$245.00 ➝ $265.00
9/20/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$278.00 ➝ $282.00
8/5/2024Bank of AmericaBoost TargetBuy ➝ Buy$240.00 ➝ $260.00
8/2/2024UBS GroupBoost TargetBuy ➝ Buy$260.00 ➝ $270.00
8/2/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$220.00 ➝ $230.00
8/2/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$213.00 ➝ $249.00
8/2/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$261.00 ➝ $277.00
8/2/2024Truist FinancialBoost TargetBuy ➝ Buy$255.00 ➝ $275.00
7/9/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$210.00 ➝ $215.00
7/8/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$258.00 ➝ $261.00
5/30/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$261.00 ➝ $243.00
4/26/2024Truist FinancialLower TargetBuy ➝ Buy$270.00 ➝ $255.00
4/26/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$234.00 ➝ $213.00
4/26/2024Robert W. BairdLower TargetOutperform ➝ Outperform$255.00 ➝ $244.00
3/25/2024ArgusUpgradeHold ➝ Buy$250.00
2/26/2024Leerink PartnrsReiterated RatingOutperform
2/26/2024Leerink PartnersInitiated CoverageOutperform$260.00
2/9/2024Evercore ISIInitiated CoverageIn-Line$240.00
1/3/2024BarclaysInitiated CoverageEqual Weight$222.00
11/17/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$259.00 ➝ $261.00
10/31/2023MizuhoLower TargetBuy ➝ Buy$257.00 ➝ $230.00
9/21/2023Bank of AmericaLower TargetBuy ➝ Buy$238.00 ➝ $230.00
9/18/2023UBS GroupLower Target$255.00 ➝ $250.00
9/18/2023Robert W. BairdLower TargetOutperform ➝ Outperform$251.00 ➝ $237.00
9/15/2023MizuhoReiterated RatingBuy ➝ Buy$257.00
9/15/2023Truist FinancialReiterated RatingBuy ➝ Buy$270.00
9/6/2023HSBCInitiated CoverageHold$210.00
8/14/2023Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$290.00 ➝ $270.00
8/3/2023Morgan StanleyLower TargetOverweight ➝ Overweight$285.00 ➝ $260.00
8/2/2023Credit Suisse GroupLower TargetOutperform ➝ Outperform$247.41 ➝ $231.00
7/31/2023Robert W. BairdLower TargetOutperform ➝ Outperform$255.00 ➝ $251.00
7/28/2023Truist FinancialLower TargetBuy$275.00 ➝ $270.00
5/16/2023MizuhoLower Target$277.00 ➝ $257.00
5/1/2023Truist FinancialLower Target$285.00 ➝ $275.00
4/26/2023Deutsche Bank AktiengesellschaftLower Target$265.00 ➝ $240.00
4/26/2023CitigroupLower Target$260.00 ➝ $235.00
3/13/2023Credit Suisse GroupLower TargetOutperform$304.00 ➝ $288.00
2/21/2023Credit Suisse GroupLower TargetOutperform$305.00 ➝ $304.00
2/21/2023Wells Fargo & CompanyLower TargetOverweight$315.00 ➝ $290.00
2/17/2023Truist FinancialBoost TargetBuy$275.00 ➝ $285.00
2/17/2023CitigroupBoost TargetNeutral$250.00 ➝ $260.00
2/17/2023Robert W. BairdBoost TargetOutperform$300.00
2/17/2023MizuhoBoost TargetBuy$250.00 ➝ $277.00
1/11/2023Robert W. BairdBoost TargetOutperform$270.00 ➝ $285.00
1/6/2023Morgan StanleyBoost TargetOverweight$290.00 ➝ $303.00
12/12/2022CitigroupDowngradeBuy ➝ Neutral$275.00 ➝ $250.00
11/23/2022Credit Suisse GroupLower TargetOutperform$308.00 ➝ $305.00
11/3/2022MizuhoLower TargetBuy$296.00 ➝ $250.00
10/31/2022Morgan StanleyLower TargetOverweight$300.00 ➝ $290.00
10/28/2022Truist FinancialLower TargetBuy$275.00 ➝ $260.00
10/28/2022CitigroupLower Target$300.00 ➝ $275.00
10/28/2022Robert W. BairdLower Target$297.00 ➝ $270.00
10/27/2022William BlairReiterated RatingOutperform
9/19/2022ArgusDowngradeBuy ➝ Hold
8/22/2022Morgan StanleyReiterated RatingOverweight$300.00
8/9/2022Credit Suisse GroupLower Target$308.00
8/4/2022Robert W. BairdBoost TargetOutperform$295.00 ➝ $297.00
8/1/2022Credit Suisse GroupLower TargetOutperform$312.00 ➝ $308.00
5/25/2022Morgan StanleyLower TargetOverweight$360.00 ➝ $300.00
5/4/2022MizuhoLower Target$354.00 ➝ $323.00
5/3/2022Deutsche Bank AktiengesellschaftLower Target$294.00 ➝ $265.00
5/2/2022Credit Suisse GroupLower Target$344.00 ➝ $312.00
4/29/2022Truist FinancialLower Target$350.00 ➝ $320.00
4/25/2022Wells Fargo & CompanyLower TargetEqual Weight$290.00 ➝ $235.00
2/14/2022Morgan StanleyLower TargetOverweight$380.00 ➝ $360.00
2/11/2022Wells Fargo & CompanyLower Target$340.00 ➝ $320.00
2/11/2022Credit Suisse GroupBoost TargetOutperform$340.00 ➝ $344.00
2/11/2022CitigroupBoost Target$340.00 ➝ $350.00
1/28/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$330.00 ➝ $294.00
12/20/2021MizuhoBoost TargetBuy$332.00 ➝ $354.00
12/17/2021Morgan StanleyBoost TargetOverweight$377.00 ➝ $380.00
12/14/2021Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$330.00 ➝ $340.00
11/1/2021Credit Suisse GroupBoost TargetOutperform$336.00 ➝ $338.00
10/29/2021Morgan StanleyBoost TargetOverweight$368.00 ➝ $377.00
8/31/2021Morgan StanleyBoost TargetOverweight$273.00 ➝ $368.00
8/20/2021Credit Suisse GroupBoost TargetOutperform$295.00 ➝ $336.00
8/19/2021MizuhoBoost TargetBuy$318.00 ➝ $332.00
7/30/2021Truist FinancialBoost TargetPositive ➝ Buy$330.00 ➝ $350.00
7/30/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$297.00 ➝ $330.00
7/30/2021MizuhoBoost TargetBuy$310.00 ➝ $318.00
7/21/2021Robert W. BairdSet TargetBuy$276.78
5/20/2021ArgusBoost TargetAverage ➝ Buy$270.00 ➝ $295.00
5/12/2021MizuhoBoost TargetBuy$267.00 ➝ $310.00
5/3/2021Truist FinancialBoost Target$300.00 ➝ $320.00
5/3/2021CitigroupBoost Target$278.00 ➝ $312.00
5/3/2021Jefferies Financial GroupBoost TargetBuy$300.00 ➝ $310.00
4/14/2021Truist FinancialBoost TargetAbove Average ➝ Buy$280.00 ➝ $300.00
4/1/2021Jefferies Financial GroupReiterated RatingBuy
2/12/2021CitigroupBoost TargetBuy$257.00 ➝ $278.00
2/12/2021JPMorgan Chase & Co.Boost TargetOverweight$261.00 ➝ $279.00
2/12/2021MizuhoBoost TargetBuy$242.00 ➝ $267.00
1/29/2021CitigroupBoost TargetBuy$249.00 ➝ $257.00
1/14/2021MizuhoBoost TargetBuy$234.00 ➝ $242.00
1/11/2021ArgusUpgradeHold ➝ Buy$245.00
1/8/2021Wolfe ResearchDowngradeOutperform ➝ Peer Perform
10/28/2020Wells Fargo & CompanyBoost TargetOverweight$225.00 ➝ $260.00
10/28/2020MizuhoBoost TargetBuy$215.00 ➝ $234.00
10/27/2020William BlairReiterated RatingOutperform
10/14/2020Jefferies Financial GroupBoost TargetBuy$183.00 ➝ $230.00
7/31/2020MizuhoBoost TargetBuy$186.00 ➝ $215.00
7/29/2020Bank of AmericaBoost TargetBuy$220.00 ➝ $240.00
7/29/2020SunTrust BanksBoost TargetPositive ➝ Buy$220.00 ➝ $240.00
7/29/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$210.00 ➝ $230.00
7/29/2020CitigroupBoost TargetBuy$214.00 ➝ $249.00
7/14/2020Bank of AmericaUpgradeNeutral ➝ Buy$194.00 ➝ $220.00
7/13/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$202.00 ➝ $217.00
6/10/2020Wells Fargo & CompanyReiterated RatingBuy
6/8/2020Robert W. BairdBoost TargetOutperform$199.00 ➝ $219.00
6/4/2020JPMorgan Chase & Co.Boost TargetOverweight$118.00 ➝ $223.00
6/2/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$210.00
5/21/2020SunTrust BanksBoost TargetBuy$200.00 ➝ $220.00
5/20/2020Morgan StanleyBoost TargetOverweight$241.00 ➝ $244.00
5/15/2020MizuhoUpgradeNeutral ➝ Buy$158.00 ➝ $186.00
(Data available from 5/13/2020 forward)

News Sentiment Rating

1.26 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 28 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/15/2024
  • 34 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/14/2024
  • 61 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/14/2024
  • 17 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/13/2025
  • 49 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/12/2025
  • 51 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/14/2025
  • 74 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
4/13/2025
  • 59 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/13/2025

Current Sentiment

  • 59 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Laboratory Co. of America logo
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Read More

Today's Range

Now: $249.91
Low: $249.38
High: $251.84

50 Day Range

MA: $233.61
Low: $212.43
High: $253.92

52 Week Range

Now: $249.91
Low: $191.97
High: $258.59

Volume

130,627 shs

Average Volume

639,035 shs

Market Capitalization

$20.92 billion

P/E Ratio

28.33

Dividend Yield

1.16%

Beta

0.82

Frequently Asked Questions

What sell-side analysts currently cover shares of Laboratory Co. of America?

The following sell-side analysts have issued stock ratings on Laboratory Co. of America in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., Deutsche Bank Aktiengesellschaft, Evercore ISI, Hsbc Global Res, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Redburn Atlantic, Robert W. Baird, StockNews.com, Truist Financial Co., and UBS Group AG.
View the latest analyst ratings for LH.

What is the current price target for Laboratory Co. of America?

0 Wall Street analysts have set twelve-month price targets for Laboratory Co. of America in the last year. Their average twelve-month price target is $270.62, suggesting a possible upside of 7.9%. Citigroup Inc. has the highest price target set, predicting LH will reach $300.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $230.00 for Laboratory Co. of America in the next year.
View the latest price targets for LH.

What is the current consensus analyst rating for Laboratory Co. of America?

Laboratory Co. of America currently has 3 hold ratings, 11 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for LH.

What other companies compete with Laboratory Co. of America?

Other companies that are similar to Laboratory Co. of America include Quest Diagnostics, DaVita, Chemed, CorVel and Amedisys. Learn More about companies similar to Laboratory Co. of America.

How do I contact Laboratory Co. of America's investor relations team?

Laboratory Co. of America's physical mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company's listed phone number is (336) 229-1127 and its investor relations email address is investor@labcorp.com. The official website for Laboratory Co. of America is www.labcorp.com. Learn More about contacing Laboratory Co. of America investor relations.





Receive Laboratory Co. of America News & Ratings Daily
Sign up to receive the latest news and ratings for Laboratory Co. of America and its competitors with PriceTargets.com’s free daily newsletter.